REGISTERED CHARITY NUMBER: 1020201
REPORT OF THE TRUSTEES AND
UNAUOITED FINANCIALSTATEMENTS FOR THE YEAR ENDED 31 MARCH 2023
FOR
THE DAVIO HIDE AsfHMA AND ALLERGY
RESEARCH CENTRE
8right Brown Limited
Chartered Accountants
Exchange House
St. Cross Lane
Newport
Isle of Wlght
P030 SBZ

THE DAVID HIDE AsfHMA AND ALLERGY
RESEARCH CENTRE
CONTENTS OF THE FINANaAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023
Page
Report of the Trustees
Independent E¥aminerfs Report
statement of Flnanclal Act￿llIeS
Balance Sheet
Note5 to the Flnancial Statements
7 to 13
Detalled Statement of Flnanrlal Actlvitles
14 to 15

THE OAVID HIDE ASTHMA AND ALLERGY
RESEARCH CENTRE
REPORT OF THE TRUSTEES
FOR ThE YEAR ENDED 31 MARCH 2023
The trustees present thelr report with the financlal statement5 of the charity for the year ended 31 March 2023. The
tru5tee5 have adoptetl the provisions of Accounting and Reportin8 by Charities.. Statement of Recommended Practice
applicable to charities preparing their accounts in accordance with the FSnanclal Reporting Standard applicable in the
UK and Republlc of Ireland IFRS 1021 (effective l January 20191.
OBJECTIVES AND AcTIV￿lES
Object5 of the charity
The charity provides the opportunity to further the knowledge of diagnosls and management of allergi¢ diseages based
on research. It secures the research and education plarform from which much has been achieved in the last two
decades.
The charity operates from a purpose-bullt centre wlthin St. Mary's Hospital and it5 main functions are..
to provide a facility for diagnosis and rnanagement of allergy-related disorders within the NHS,.
to increase the understanLling of ihe causes and treatment of allerBlc dlseases by means of an evolving pro8ramme of
research,. and
to offer training In Clinbcal allergy to d(Ktors, medical students and other health professionals.
In sflaplng our ot)jectives for the year and planning our activities. the trustees have considered the Charity
Comrnission's guidance on publlt beneflt.
ACHIEVEMENT AND PERFORMANCE
Review of the development and achlevement of the d￿rItY
In 2022 research activity continued at the David Hide Asthma & Aller8y Centre. The Research team has been reduced
over the year to reflect actlvlty but continue to delive¥ to tar8et.
Study activlty:
Pattems of adult food aller8y in the UK populatlon IPAFA 5taBe 31. funded by the Food Standards Agency IFSAI and
sponsored by Manchester University NHS Foundation Tyust. The Davld Hlde Centre carried out recruitment of
indsvlduals from the Isle of Wight Birth Cohort who had probable food aller8ies.
The Research team had the opportunity to set up a commercial CRN Wessex led Immunisation Study. The Harmonle
study is looking at a nEw medicine which protects ag3in5t respiratory syncytial virus IRSVI. The Study Is looklnÈ at how
strongly babies can be protetted frtsm serious illness due to RSV infection by comparing a single dose of antibody with
no Intervention.
The Preschool wheeze study (Breathing Togetherl wa5 complèted, endlng the study by following up the children at 4-5
years of age.
EOSA- Epi8enetics of Sèvere Asthma Study re4tarted early in 2023. recrultln8 adults with mild asthma and healthy
volunteeTS Ino asthma). Further fvndlng ffom the NIH IUSAI was secured thfough the University of California, Sa
Oie@o.
FINANCIAL REVIEW
Reserves pollcv
It 15 the policy of the charity to malntain unrestricted fvnds, which are thè freè reserves of the charlty, at a level whlch
equate5 to at least twelve months unrestricted expenditure. At this level the ie5eives provide suffl¢ient funds to
continue the activities of the charity. should there be a significant drop in fundin& while new research projects are put
in place. In pradiee, the charity holds additional reserves to support over 10 year5 Qf expenditure at the current level
held to support the future funding of the charities objectives and to maintain expenditure in a(Jvance of È13nt funding
being received.
Page I

THE DAVID HIDÈ ASTHMA AND AILERGY
RESEARCH CENTRE
REPORT OF THE TRUSTEES
FOR THE VEAR ENDED 31 MARCH 2023
FINANCIAL REVIEW
Result5 for the flnanclal year
Total income for the year amounted to £115,71612022.' £66,074). Costs relating to charitable activities amounted to
£29,66912022.' £25,735). UnrestrScted funds and restrlcted funds carried forward ai the end of the year amounted to
£385,02612022.' £298,979).
FUTURE PLANS
Planning for future studies continue5:
IW 8irth Cohort 34 Year Follow-up will start laier in 2023.
PREVENT Prlm3ry Preventlon of Asthma using House Dust Mite Immunotherapy. The proposal will be submitted to thè
NIH in September 2023.
Applications to the MRC and NIH- related to House Dusi Mite Allergy
Food allergy prevention trial- PGfAR- stage 2 application is due to be submitted August 2023.
STRUCTURE, GOVERNANCE AND MANAGEMENT
Governin8 document
The charity 15 CQlltrollefl by its 8overnlng document. a deed of trust and tonstitules an unincorporated charity-
Organisatlon
The trustees who served during the year are set out below. The trustees meet regularly and meetlngs are presided over
by a Chairman who is appoinled annually.
REFERENCE AND ADMINisfRATNE DETAILS
RegI5tered Charity number
1020201
Principal address
The David Hide A5thrna and Allergy
Research Centre
st Mary's Hospital
Newport
Isle of Wight
P030 STG
Tru5tee5
Dr C J A Andrews
DrYHHide
Mis E M Bell
Mfs J A Griffin
Dr M R Stainer
Mrs S Matthews
Mrs C Stone
PaÉe 2

INDEPENDENT EXAMINER'S REPORT TO TFIE TRUSTEES OF
THE DAVIO HIDE ASTHMA AND ALLERGY
RESEARCH CENTRE
Independent examinerf5 report to the trustèes olThe Davld Hlde Asthma and Allergy Research Centre
I report to the ch3rity trvstees on my examination ol the accounts of The David Hide Asthma and Allergy Re5earth
Centre Ithe Trust) for the year ended 31 March 2023.
Responslbllhtie5 and b3515 of report
As the charty trustees of the Trust you are responslble for the preparatlon of the accounts in accordance with the
requirements of the ChaTlties Act 20111.the Act'l.
I report in respect of my examlnatlon of the Trtjst's accounts earried out tsn(Jer Sectlon 145 of the Act and in carrying
out my examination I have followed 311 appllcable Direction5 given by the Charity Commi551on under Section 14515llbl
of the Act.
Indèpendent examiner's statement
I havÈ completed my examination. I conflrm that no material matters have come to my attention In CDnnettlon wlth
the examinatiDn giving ffle cause to believe that in any material respect..
accountlng records were not kept in respect of the Trust as required by 5ertlon 130 of the Act,. or
the accounts do not 3ccord with those records; or
the accounts do not comply with the applicable requirements concerning the form and content of accounts set
out In the CharltSes IAccounts and Reports) Regulations 2008 other than any requlrement that the accoun15
8ive a true and fair view which is not a matter considered as part of an IndopendeTht examlnation.
I have no concerns and have come across no other matter5 in connection with the examination to whleh attention
shtsuld be drawn In thls report in order to enable a proper understanding of the account5 to be reached.
DIPSteveMsACA
Bright Brown Limlted
Chartered Accountants
Sl. Cross Lane
Newport
P030 5B2
Date: ,
Pa8È 4

THE DAVID HIDE ASTHMA AND ALLERGY
RESEARCH CENfRE
REPORT OF THE TRUSTEES
FOR THE YEAR ENDEO 31 MARCH 2023
REFERENCE AND AOMINISTRATIVE DETAILS
Independent Examiner
DIP5tevensACA
Bright 8rown Llmlted
Chartered Aceount3nts
Exchange House
St. Cross Lane
Newport
Isle of Wight
P030 5BZ
Approved by order of the board of trustees Dn
. and slgned on It5 behalf bv..
DrCJAA
ws- Trustee
Page 3

THE DAVID HIDE ASTHMA AND ALLERGY
RESEARCH CENTRE
BALANCE SHE
31 MARCH 2023
2023
UnTestrictÈd
funds
2022
Total
f￿ndS
Note5
FIXED ASSEYS
Tan£ible asset5
18,452
21,266
CURRENT ASSErs
Oebtors
Cash at baTrk
519
367,515
126
278,8S5
368,034
278,981
CREDITORS
AmotJnt5 falllng due wlthln one yeaf
11,4601
11,2681
NET CURRENT ASSETS
366,574
277,713
TOTAL AS5EtS LESS CUARENT UABILITIES
385,026
298,979
NET ASSETS
385,026
298,979
FUNDS
Unrestricted funds
385,026
298,979
TOTAL FUNDS
385,026
298.979
The
Inancial statement5 were approved by the Board of TNstee5 and authorised lor issue on
.3.......... and were sSgned on Its behalf bv..
Orc
drews-Tru5tee
The notes form part Lif these financial statements
Page 6

THE DAVID HIDE A5THMAAND ALLERGY
RESEARCH CENTRE
STATEMENT OF FINANCIAL AcnviTIES
FOA THE YEAR ENDED 31 MARCH 2023
2023
Unrestricted
funds
2022
Total
lund5
Notes
INCOMEAND ENDOWMENTS FROM
Donations and legacies
2,827
4,933
Charltable actlvltle5
Research, dia&inosls and management of allerglc
diseases
112,085
60,969
Invèstment Income
Other income
779
25
172
Total
115,716
66,074
EXPENDITURÉ ON
Charitable actlvltle5
Aesearch, diagnosis and managemelbt of aller8iC
diseases
29.669
25,735
N￿]NComE
86.047
40,339
RECONCILIATION OF FUNDS
Total funds brought forward
298,979
258,640
TOTAL FUN05 CARRIED FORWARO
385,026
298.979
The notes form part of these flnancial statements
Page 5

THE DAVID HIDE ASTHMA ANO ALLERGY
RESEARCH CENTRE
NOTES TO THE FINANCIAL STATEMENTS
FOR THEVEAR ENDED 31 MARCH 2023
ACCOUNTING POLICIES
Bas55 of preparlngthe flnanclal statements
The financial statements of the charity, which Is a public benefit entity under FRS 102, have been prepared in
accordance with the Charities SORP IFRS 1021 'Accounting and Reportlng by Charities.. Statement of
Recommended PrJttbce applicable to charitie5 preparing their accounts in accordance wlth the Financial
Reportlng Standard applicèble in the UK and Republlc of Ireland IFRS 1021 leffective I january 20191,. Financial
Reporting Standard 102 'The Finaftclal Reporting Standard applicable in the UK and Republic of Ireland, and the
Charities Act 2011. The financial Statements have been prepared under the historlcal c05t convention.
Income
All Income is recognlsed in the Statement of Financial Activitle5 once the charity has enlitlempnt to the fund5, it
is prabable that the Income wlll be received and the amount can be measurèd reliablv.
Empendlture
Liabilitie5 are ie¢oEnised as expendlturè as soon as there is a legal or constructive obligation committlng the
Charity to that expenditure, it Is probable that a transfer of economic benefits will be required in settlement
and the amount of the oblieation can bè measured reliabty. EKpendlture is accounted for on an accruals basls
d has been classifled under headings that aggregate all cost related to the categoTY. Wheie costs cannot be
dlrectly attributed to particular headings they have been allocated to activities on a basis con51Stent wlth the
use of resources.
Tan81b￿ fixed assets
Depreciation is provided at the folluwin8 annual rates in Ofdgr to write ctff each a55et over its estimated useful
Building
Equlpment
Over fifty years
Straight line over 3 to 7 years
Fund at¢aunt5ng
General Fun
The charity's genèral funds consist of funds whlch the charity may use for its purpose5 at tts dlscretion.
Restricted Fund5
nwme received into the restricted fund FepresentS the ￿e￿Ipt of funds for specific purposes. Expenditure
charged against the restricted lunds represents revenue c05t5 incurred during the year for the purpose
specified by the fund.
Desi
èd Funds
Designated fund5 are funds established by the committee from time to time for speclfic projetts or purpL75e5,
are not in any way restricted and any 5urplu5 or deficit will bè transferred tolfrom the general purpose fund
when the designated fund In dosed.
Page 7
continued...

THE DAVID HIDE ASTHMA AND ALLERGY
RESEARCH CENTRE
NOTES TO THE FINANCIAL STATEMENTS- contlnyed
FOR THE YEAR ENDED 31 MARCH 2023
INVESTMEfrIT INCOME
2023
2022
UK Bank interest
779
172
TRUSTEES, REMUNERATION AND BENEFITS
There were no trustees, ￿MUneratIOn or other benefits for the year ended 31 March 2023 nor for the year
ended 31 March 2022.
Trustees, expenses
There were no trustees, expenses paid for the year ended 31 March 2023 nor foy the year ended
31 March 2022.
STAFF COSTS
The average monthw number of employees during the year was as follows..
2023
2022
Research. dSagnosis and management
No ernployeE5 received emolument5 In excess of £60.C￿.
All employee c05tS shown above are Contributions to NHS Trust wages that have been recha¥ged to the charity.
COMPARATIVES FOR THE STATEME￿ OF FINANCIAL ACTIVITIES
Vnre5trlrted
funds
INCOME AND ENDOWMENTS FROM
Donations and legacie5
4,933
Charltable actl¥ltle5
Research, diagnosis and management of
311er8ic diseases
60,969
Investment income
172
Total
66,074
EXPENDITURE ON
Charitable artivltle5
Research, cliagnosis and management of
aller8ic disease5
25.735
NET INCOME
40,339
Page 8
continued...

THE OAVID HIDE ASTHMA AND ALLERGY
RESEARCH CENTRE
NOTES TO THE FINANCIAL STATEMENTS- contlnued
FOR THE YEAR ENDED 31 MARCH 2023
COMPARATNES FOR THE STATEMENT OF FINANCIAL AcnviriES- Contlnued
Unrestricted
fvnds
RECONCILIATION OF FUNDS
Total funds brought forward
258,640
TOTAL FUNDS CARRIED FORWARD
298.979
TANGIBLE FIXED ASSETS
Building
Equipment
Tota15
COST
At l April 2022
Dlsposals
30,0
41,185
112,9961
71,185
112,9961
At 31 March 2023
30,OCQ
28,189
58,189
DEPRÉCIATION
At l April 2022
Charge for year
Ellminated on disposal
15,000
600
34,919
2,215
112,9971
49,919
2,815
112,997
At 31 March 2023
15,600
24,137
39,737
NET BOOK VALUE
At 31 March 2023
14.400
4,052
18,452
At 31 March 2022
15,000
6.266
21,266
All of thè fSxed assets are used in the diwecl furtherance of the charity's object4ves.
DEBTORS: AMOUTrUS FALLING DUE WITHIN ONE YÉAR
2023
2022
other debtors
519
126
Page 9
continued...

THE OAVID HIDE ASfHMA AND ALIERGY
RESEARCH CENTRE
NOTES TO THE FINANCIAL STATEMENTS- contSnued
FOR THE YEAR ENDED 31 MARCH 2023
CRED￿oR5., AMOUNTS FALLING DUE WITHIN ONE YEAR
2023
2022
Sundry ¢redltors and accrued expenses
1,460
1,268
MOVEMENT IN FUNDS
Net
movement
in fvn(Is
At
31.3.23
At 1.4.22
Unrestrlcted funds
Resèarch, diagnosis and management of
allergic di5ease5
Pl Fund (H Ramesh)
Pl Fund IR Kurukulaafatchy}
Pl Fund IG Robert51
258,(K)9
9,121
18.829
13,020
89,182
19361
14,0171
1,818
347,191
8,185
14,812
14,838
298.979
86,047
385,026
TOTAL FUNDS
298,979
86,047
385.026
Net movement in fund5, inclknded in the above are as follows..
Incomlng
resources
Resources
expended
Movement
in funL45
Unre5trIcted funds
Research, dlagnosls and management of
allergic disea5e5
Pl Fund (H Rameshl
Pl Fund IR Kurukulaaratchyl
Pl Fund IG Roberts)
101,732
112,5501
19361
15,6691
110,5141
89,182
19361
14,0171
1,818
1,652
12,332
115,716
129,6691
86,047
TOTAL FUNDS
115,716
129,6691
86,047
Page 10
gntinued...

THE DAVID HIDE ASTHMA AND ALIERGY
RESEARCH CENTRE
NOTES TO THE FINANCIAL STATEMENTS- contlnued
FOR THE YEAR ENDED 31 MARCH 2023
MOVEMENT IN FUNDS- contlnued
Comparatl¥esfoY movement In funils
Net
movement
in fund5
At
31.3.22
At 1.4.21
Unrestrlrted fvnds
Research, diagnosis and managemenl of
Ilerglc diseases
Pl Fund (H Rameshl
Pl Fund IR Kurukulaaratchyl
Pl Fund IG Roberts)
233.639
9,121
13,480
2.400
24,370
258,009
9,121
18,829
13,020
5,349
10,620
258,640
40,339
298,979
TOTAL FUNDS
258,640
40.339
298,979
Comparatlve net movement in funds, included in the above are as follows..
Incoming
resources
Resources
expended
Movement
In funds
Unrestrirted fvnds
Research, diagnosis and management of
allergic diseases
Pl Fund IR Kurukulaaratchyl
Pl Fund IG Robert51
50,105
5,349
10,620
125,7351
24,370
5,349
10,620
66,074
125,7351
40,339
TOTAL FUNDS
66,074
12S,7351
40,339
Page 11
continued...

THE DAVID HIDE ASTHMA ANO ALLERGY
RESEARCH CENTRE
NOTES TO THE FINANCIAI STATEMENTS- contlnued
FOR THE YEAR ENDED 31 MARCH 2023
MOVEMENT IN FUNDS- continued
A current year 12 month5 and prior year 12 month5 ¢omblned position is as follows..
Net
movement
in furbds
At
31.3.23
At 1.4.21
UnrestrSrted funds
Research, di38nosis and management of
allergic diseases
Pl Fund IH Rameshl
Pl Fund IR Kurukulaaratchyl
Pl Fund IG Roberts)
233,639
9,121
13,480
113,552
19361
1,332
12,438
347.191
8,185
14,812
14,838
258,640
126,386
385,026
TOTAL FUNDS
258,640
126,386
385,026
A current year 12 months and prior year 12 months combined net movement in funds, Included in the above
are as follows..
Incoming
resources
ResourtÈs
expended
Movement
in funds
Unrestrlrted funds
Research, diagnosis and management of
allerÉic diseases
Pl Fund IH Ramesh)
Pl Fund IR Kurukulaar3tchvl
Pl Fund IG ftobertsl
151,837
138,2851
19361
15,6691
110,5141
113,552
19361
1,332
12,438
7,001
22.952
181,790
155,4041
126,386
TOTAL FUNDS
181,790
155,4041
126,386
The research. diagnosis and mana8ement of allergic dlsease5 fund 5s made up of fund5, les5 related
expendlture, for the continuance of the educational work undertaken by the Eentie. Expense5 may in¢ludè
subscrlptions to asthma and allergy related organi5ation5, attending meetings. courses and conference5
Including re81Stration. travel expenses and accommodation. It will also fund the purchase of relevant journals
and books for the Centre library.
The Pl Funds are designated funds made up of funds, less related expenditure, for research by Dr Hasan and Dr
Ramesh. Expensès will be allocated at the discretion of the dottors.
Page 12
conilnued...

THE DAVID HIDE ASTHMA AND ALLERGY
RESEARCH CENTRE
NOTES TO THE FINANCIAL STATEMENT5- ¢ontlnued
FOR THE YEAR ENDED 31 MARCH 2023
io.
RELATED PARTY DISCLOSURES
Thère were no ielated part.y transactions for the year ended 31 Marrh 2023.
Ll.
ANALYSIS OF NET A55ETS BETWEEN FLITrIOS
TanÈible
flxed assets
Net current
assets
Total
Restricted fvnds..
Unrestrlcted funds:
29,805
257,960
287,765
29,805
257,960
287,765
Page 13

THE DAVID HIDE ASTHMA ANO ALLERGY
RESEARCH cE￿rRE
OETAILED STATEMENT OF FINANCIAL AcnviTIES
FOR THE YEAR ENOED 31 MARCH 2023
2023
Total
funds
2022
Total
funds
INCOME AND ENDOWMENTS
Donatlons and le&acles
Donations
Pollen fundin8
300
2,527
300
4.633
2,827
4.933
Investment In¢ome
UK Bank inteFe5t
779
172
Charltable a¢ti¥lties
Grants
Pl Ftjnd
98,101
13,984
45.000
15,969
112,085
60,969
Othpr Income
Othèr income
25
Total Sncomlng resources
115,716
66,074
EXPENDITURE
Charitable activltle5
Telephone and internet
Postage and statiorbery
Mlscellaneous
Travel
Gifts. vouchers and refreshmènts
Medic31 supplies and repairs
Financial service5
Course and conferènce costs
Subscription5
l.T costs
Contrlbution to Dy50n
BreathinK together charge
studentship support
Depreciation of tangible fixed èssets
Loss on sale of tangible fixed a55ets
436
125
1,456
536
500
4,898
1,890
301
415
2,593
102
7,342
1,932
185
4,924
1,500
5.931
10,329
2,814
2,814
1,701
28,493
24.631
This page doe5 not form part of the statutory financial Statements
Page 14

THE DAVID HIDE ASTHMA AND ALLERGY
RESEARCH CENTRE
DETAILED STATEMENT OF FINANCIALACTIVITIES
FOR THE YEAR ENOED 31 MARCH 2023
2023
Total
funds
2022
Total
funds
Support costs
Governince costs
Independènt ex3mlners fees
1,176
1.104
Total resources expèndèd
29,669
25,735
Net Income
86,047
40,339
This page doe5 Ilot form part of the statutory financial statements
Page 15